tirzepatide at 15 mg 15mg ₹ 1800/vial | Mounjaro in Nagpur Tirzepatide (5mg/10mg/15mg/20mg/30mg)

Diabetes/Metab

Analyzing data for the 80 percent of participants not taking a GLP-1 allowed the researchers to factor in diabetes severity

For Elizabeth Kenly, 59, of Graham, North Carolina, the FDAs decision gives her peace of mind. Kenly was prescribed a compounded version of tirzepatide in March after she had trouble finding Wegovy because it was in shortage

Key Takeaways Microdosing could theoretically reduce peak-to-trough ratios by 28-38%, potentially minimizing side effects Successful precedents exist with insulin and growth hormone therapies using similar principles Mathematical models suggest maintained efficacy (~75-100%) with appropriate dose adjustments No clinical trials have validated microdosing for GLP-1 agonists - all evidence is theoretical or anecdotal 55% of microdosers make decisions without physician consultation, raising safety concerns What Is Retatrutide Microdosing